Senores Pharmaceuticals Ltd Annually Results

Gross Sales

398.25

214.52

35.34

14.17

Excise Duty

0

0

0

0

Net Sales

398.25

214.52

35.34

14.17

Other Operating Income

0

0

0

0

Other Income

19.26

2.82

3.68

0.46

Total Income

417.51

217.34

39.02

14.63

Total Expenditure

308.55

172.92

22.67

12.22

PBIDT

108.96

44.42

16.35

2.41

Interest

21.55

9.45

2.14

0.57

PBDT

87.41

34.97

14.22

1.85

Depreciation

16.84

10.02

1.78

0.71

Minority Interest Before NP

0

0

0

0

Tax

15.56

8

1.43

0.17

Deferred Tax

-3.33

-15.76

2.58

-0.02

Reported Profit After Tax

58.34

32.71

8.43

0.99

Minority Interest After NP

-0.22

1.26

0

0

Net Profit after Minority Interest

58.56

31.45

8.43

0.99

Extra-ordinary Items

0

0

0

0

Adjusted Profit After Extra-ordinary item

58.56

31.45

8.43

0.99

EPS (Unit Curr.)

16.12

13.67

8.87

1.2

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

46.05

30.51

9.82

8.74

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

27.35

20.7

46.26

17

PBDTM(%)

21.94

16.3

40.23

13.05

PATM(%)

14.64

15.24

23.85

6.98